Literature DB >> 8111710

Omental-mesenteric inflammatory pseudotumor. Cytogenetic demonstration of genetic changes and monoclonality in one tumor.

S P Treissman1, D A Gillis, C L Lee, M Giacomantonio, L Resch.   

Abstract

BACKGROUND: Extrapulmonary inflammatory pseudotumor (plasma cell granuloma) is an uncommon lesion in adults and children, and little is known either of its etiology or clinical characteristics. However, it remains a significant source of morbidity to patients and confusion to clinicians.
METHODS: Case reports are presented of three patients with intraabdominal inflammatory pseudotumor who recently underwent surgery. A review of the recent world literature is also presented. Clinical and laboratory characteristics of omental-mesenteric inflammatory pseudotumor are reviewed along with a discussion of its etiology.
RESULTS: Cytogenetic data from cells of one patient show a derivative chromosome evolved from a translocation between the long arm of chromosome 2 and the short arm of chromosome 9 [(2;9)(q1,3;p2,2)].
CONCLUSIONS: The lesion is monoclonal, and genetic changes may play a crucial role in the development of this neoplasm. Omental-mesenteric inflammatory pseudotumor appears to represent a distinct clinicopathologic entity as a benign neoplasm in children.

Entities:  

Mesh:

Year:  1994        PMID: 8111710     DOI: 10.1002/1097-0142(19940301)73:5<1433::aid-cncr2820730518>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms.

Authors:  M Ladanyi
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors.

Authors:  B Lawrence; A Perez-Atayde; M K Hibbard; B P Rubin; P Dal Cin; J L Pinkus; G S Pinkus; S Xiao; E S Yi; C D Fletcher; J A Fletcher
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  EML4-ALK Rearrangement and Its Therapeutic Implications in Inflammatory Myofibroblastic Tumors.

Authors:  Fernando Vargas-Madueno; Edwin Gould; Raul Valor; Nhu Ngo; Linsheng Zhang; Miguel A Villalona-Calero
Journal:  Oncologist       Date:  2018-05-08

Review 4.  Mesenteric inflammatory pseudotumor: a case report and comprehensive literature review.

Authors:  Yusuf Yagmur; Sami Akbulut; Serdar Gumus
Journal:  J Gastrointest Cancer       Date:  2014-12

5.  Inflammatory myofibroblastic tumor of the small bowel mesentery: an unusual cause of abdominal pain and uveitis.

Authors:  Audrey H Choi; Olga L Bohn; Timothy D Beddow; Christopher R McHenry
Journal:  J Gastrointest Surg       Date:  2011-01-05       Impact factor: 3.452

6.  Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor.

Authors:  J A Bridge; M Kanamori; Z Ma; D Pickering; D A Hill; W Lydiatt; M Y Lui; G W Colleoni; C R Antonescu; M Ladanyi; S W Morris
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

7.  Inflammatory pseudotumor of the retroperitoneum in a child.

Authors:  B Gignoux; J Chappuis; P Carlioz
Journal:  Pediatr Surg Int       Date:  1997-07       Impact factor: 1.827

8.  Inflammatory pseudotumor of the pancreas.

Authors:  S H Kroft; S J Stryker; J N Winter; G Ergun; M S Rao
Journal:  Int J Pancreatol       Date:  1995-12

9.  Fibroinflammatory biliary stricture: a rare bile duct lesion masquerading as cholangiocarcinoma.

Authors:  T Clark Gamblin; A M Krasinskas; A S Slivka; M E Tublin; Jake Demetris; Eveline Shue; Susan Caro; J Wallis Marsh; A James Moser
Journal:  J Gastrointest Surg       Date:  2008-12-05       Impact factor: 3.452

10.  Exophytic inflammatory myofibroblastic tumor of the stomach in an adult woman: a rare cause of hemoperitoneum.

Authors:  Seong-Heum Park; Jong-Han Kim; Byung Wook Min; Tae Jin Song; Gil Soo Son; Seung Joo Kim; Sang Woo Lee; Hwan-Hoon Chung; Ju Han Lee; Jun Won Um
Journal:  World J Gastroenterol       Date:  2008-01-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.